Please provide your email address to receive an email when new articles are posted on . Perceptual learning significantly improved spectacle-corrected distance visual acuity. Patients assigned to ...

Finely tuned eye movements are instrumental in enhancing visual acuity, according to findings of a study published in Nature Communications. Finely tuned eye movements are instrumental in enhancing ...

In diabetic macular edema, faricimab can improve visual acuity for treatment-naïve eyes or sustain vision for those ...

The objective of this study was to investigate preoperative factors associated with postoperative visual acuity outcomes and to develop a model to predict visual acuity prognosis. A retrospective ...

Objectives (1) To test the consistency and ease with which number-plates of different component figures can be read under DVLA driving test conditions; (2) to test the relative difficulty of reading ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. All nine eyes reached distance visual acuity of 20/30 or ...

The Waterloo Differential Acuity Test (WatDAT) – which was developed with funding from Fighting Blindness Canada – assesses ...

Three visual acuity tests taken at home produce results comparable to those achieved with standard tests taken in the office, researchers say. All the tests are free. Two measure near vision, and the ...

Online eyewear and vision care company Visibly announced it had received FDA 510(k) clearance for its at-home vision test. The Visibly Digital Acuity Product uses a touchscreen mobile device, like a ...

TH103 showed mean 10-letter gain in visual acuity and rapid, robust anatomic improvement at Month 1, following a single injectionTH103 was ...

Visual acuity is a measure of how small a detail that is visible can be, and still be identified by a person. The most common way of testing vision is to use an eye chart, (the kind that you see in an ...

Aviceda Therapeutics ("the Company" or "Aviceda"), a clinical-stage biotechnology company developing innovative therapies for retinal diseases, today announced topline results from its SIGLEC Phase 2b ...